United States influenza activity has surpassed the national baseline of 2.9%, reaching 3.2% of outpatient visits this week.
As the season begins in earnest, the Centers for Disease Control and Prevention (CDC) confirmed five pediatric deaths nationwide, including two reported this week, as regional health departments report rising transmission across several states.
Clinical Essentials for Seasonal Influenza
- Early-Season Velocity: While current influenza activity is higher than typical for mid-November, clinical data does not yet indicate a more severe seasonal peak.
- Diagnostic Monitoring: Influenza A, specifically the H1N1 strain, is the predominant circulating virus, contributing to an 11.3% test positivity rate.
- Preventative Measures: Public health officials emphasize that vaccination remains the most effective intervention to disrupt transmission chains and protect high-risk populations.
Influenza Activity Varies Significantly by Region
The current respiratory illness landscape shows significant geographic variation. According to the CDC, influenza activity is classified as high or very high in California, Louisiana, Oregon, South Carolina, Tennessee, Texas, and Washington state. In Florida, the Department of Health reports that most counties are experiencing an uptick in influenza-like illness (ILI).
Notably, Florida’s state-specific metrics reflect a Walgreens Flu Index score of 6.35, significantly higher than the national score of 3.6.
Benjamin Anderson, a professor with the University of Florida Department of Environmental and Global Health, attributed this early-season spike to a combination of cooling temperatures and increased social contact.
“We typically will see the majority of influenza cases happening in late December to early January, but it does fluctuate year to year and doesn’t always follow the same peak timeline,” Anderson said. He said that while many cases follow a steady rise during the autumn months, current data suggests a need for vigilant monitoring as cold fronts move across the country.
“This early-season influenza activity is currently higher than typically observed at this time of year, but an earlier increase in activity does not necessarily lead to a higher seasonal peak or greater overall severity,” the Centers for Disease Control and Prevention (CDC) said.
Multiple Pathogens Circulate Alongside Influenza a H1N1
While influenza claims the current headlines, the CDC’s respiratory illness update indicates that other pathogens are also circulating. Rhinovirus, enterovirus, and adenovirus levels are currently elevated. Wastewater surveillance, which serves as a leading indicator of community viral activity, shows moderate levels of COVID-19, though reported influenza and respiratory syncytial virus (RSV) remain at lower levels.
The predominant influenza strain, Influenza A H1N1, is a descendant of the 2009 pandemic virus. It was reported that while this strain is colloquially referred to as “swine flu,” it has long been established as a seasonal human virus. Unlike “variant” influenza—which describes transmission from swine to humans—this seasonal variant is monitored through standard clinical surveillance.
| Metric | Current National Data |
|---|---|
| Outpatient ILI Visits | 3.2% (Baseline: 2.9%) |
| Flu Test Positivity | 11.3% |
| Cumulative Hospitalizations | 36,000 |
| Cumulative Deaths | 2,100 |
Consult a Doctor Regarding High Risk and Vaccine Contraindications
Medical intervention is critical for individuals at high risk of complications, including young children, the elderly, and those with immunocompromised states. While vaccination is widely recommended, patients should consult their primary care physician regarding specific contraindications, such as a history of severe allergic reaction to previous flu vaccines.
“When we have higher percentages of the population covered, it helps create disruption in the transmission of the virus,” Benjamin Anderson, a professor with the University of Florida Department of Environmental and Global Health, said, noting that even for individuals who have already contracted the flu, a subsequent vaccination may serve as a booster to provide additional immunological protection.
Patients experiencing high fevers, persistent respiratory distress, or rapid worsening of symptoms should seek medical evaluation to rule out secondary bacterial infections, such as the group A Streptococcus or pertussis cases currently noted by the CDC.
The CDC maintains that the 2026-2027 respiratory season is expected to mirror the previous year’s trajectory, though it remains too early to determine final vaccine effectiveness or which specific viral strains will predominate throughout the winter.
